Yıl: 2022 Cilt: 54 Sayı: 1 Sayfa Aralığı: 115 - 119 Metin Dili: İngilizce DOI: 10.5152/eurasianjmed.2022.22325 İndeks Tarihi: 24-05-2023

Silently Proliferating: Cancer

Öz:
Cancer is a health problem that has existed for years and frequently affects tissues and organs. Although some standards have been set for its treatment, different treatments and approaches are used for each type of cancer. The treatment process and having to live with cancer drag the individual to a difficult process that affects the individual negatively. Problems such as the severe course of the disease, taking longer than expected treatment, and having many side effects reduce the individual's physical performance and activities of daily living. Therefore, this situation reduces the quality of life and causes the general well-being of the individual to be negatively affected at the psycho-social level. In order to cope with the problems that cancer patients experience, it is important to support them physically, mentally, emotionally, socio-culturally, and spiritually. The decrease in the quality of life of the caregiver also affects the quality of care and therefore the quality of life of the patient. For this reason, it is necessary to determine how patients and caregivers perceive the disease, reduce their psychological anxiety and pain, as well as the factors affecting this perception, and ensure their compliance with treatment.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Derleme Erişim Türü: Erişime Açık
  • 1. Global Burden of Disease Cancer Collaboration, Fitzmaurice C, Dicker D, et al. The global burden of cancer 2013. JAMA Oncol. 2015;1(4):505-527. [CrossRef]
  • 2. Baykara O. Kanser tedavisinde güncel yaklaşımlar. Balıkesir Sağlık Bilimleri Derg. 2016;5(3):154-165.
  • 3. Wang YH, Li JQ, Shi JF, et al. Depression and anxiety in relation to cancer incidence and mortality: a systematic review and meta-analysis of cohort studies. Mol Psychiatry. 2020;25(7):1487- 1499. [CrossRef]
  • 4. Kars A, Sahin A, Kılıc K, Sakat MS, Bilen A. Systemic immune inflammation index in differentiated thyroid cancers. Acta Otorhinolaryngol Ital. 2022;42(2):150-154. [CrossRef]
  • 5. Yanez B, Oswald LB, Baik SH, et al. Brief culturally informed smartphone interventions decrease breast cancer symptom burden among Latina breast cancer survivors. Psycho Oncology. 2020;29(1):195-203. [CrossRef]
  • 6. Purut HP, Burcu G, Akbal Y, Özdemir VA, Çol BK. Kemoterapi alan kanser hastalarında görülen semptomlar ve tamamlayıcı terapi uygulamaları kullanımları. Sağlık Akademisyenleri Derg. 2022;9(3):211-219.
  • 7. Ölmez N, Karadağ E. Ayaktan kemoterapi alan kanserli hastaların spiritüel iyilik hali ve psikolojik dayanıklılık düzeyi arasındaki ilişki. Sakarya Tıp Derg. 2022;12(3):390-402.
  • 8. Yılmaz A, Tekin SB, Bilici M, Yılmaz H. The significance of controlling nutritional status (CONUT) score as a novel prognostic parameter in small cell lung cancer. Lung. 2020; 198(4):695-704. [CrossRef]
  • 9. Demirkaya-Miloglu F, Kadioglu Y, Bilici M, Tekin SB, Ozturk M. Levels of vitamin K3 in healthy volunteers and in patients with different types of stomach cancer after a single vitamin K3 administration. J Liq Chromatogr Relat Technol. 2013;36(11):1467-1477. [CrossRef]
  • 10. Bulut I, Meral M, Kaynar H, Pirim I, Bilici M, Gorguner M. Analysis of HLA class I and II alleles regarding to lymph node and distant metastasis in patients with non-small cell lung cancer. Lung Cancer. 2009;66(2):231-236. [CrossRef]
  • 11. Rahman MM, Behl T, Islam MR, et al. Emerging management approach for the adverse events of immunotherapy of cancer. Molecules. 2022; 27(12):3798. [CrossRef]
  • 12. Akgun M, Kantarci M, Cayir K, et al. Stereological evaluation of tumor regression rates in lung cancer using CT via the cavalieri method. Eurasian J Med. 2008;40(3):109-114.
  • 13. Bahçeci A, Paydaş S, Ak N, et al. Efficacy and safety of trastuzumab emtansine in her2 positive metastatic breast cancer: real-world experience. Cancer Investig. 2021;39(6-7):473-481. [CrossRef]
  • 14. Inal A, Akman T, Yaman S, et al. Pathologic and clinical characteristics of elderly patients with breast cancer: a retrospective analysis of a multicenter study (Anatolian Society of Medica Oncology). Int Surg. 2014;99(1):2-7. [CrossRef]
  • 15. Özmen V, Özmen T, Doğru V. Breast cancer in Turkey; an analysis of 20.000 patients with breast cancer. Eur J Breast Health. 2019;15(3):141-146. [CrossRef]
  • 16. Ogundoyin SO, Ogundoyin OO. An ıncrease in the ıncidence of breast cancer: has the media done enough in Nigeria? Afr Commun Res. 2019;8(1):77.
  • 17. Conant EF, Barlow WE, Herschorn SD, et al. Association of digital breast tomosynthesis vs digital mammography with cancer detection and recall rates by age and breast density. JAMA Oncol. 2019;5(5):635-642. [CrossRef]
  • 18. Johansson A, Christakou AE, Iftimi A, et al. Characterization of benign breast diseases and association with age, hormonal factors, and family history of breast cancer among women in Sweden. JAMA Netw Open. 2021;4(6):e2114716. [CrossRef]
  • 19. Sharma R. Breast cancer incidence, mortality and morta lity- to-in ciden ce ratio (MIR) are associated with human development, 1990-2016: evidence from Global Burden of Disease Study 2016. Breast Cancer. 2019;26(4):428-445. [CrossRef]
  • 20. Köksal NG. Meme kanserinde tarama ve erken tanı. Doğu Karadeniz Sağlık Bilimleri Derg. 2022;1(2):50-56.
  • 21. Ginsburg O, Yip CH, Brooks A, et al. Breast cancer early detection: a phased approach to implementation. Cancer. 2020;126(Suppl 10): 2379-2393. [CrossRef]
  • 22. Shah SC, Kayamba V, Peek Jr RM, Heimburger D. Cancer control in low-and middle-income countries: is it time to consider screening? J Glob Oncol. 2019;5(5):1-8. [CrossRef]
  • 23. Çevik C, Güneş S, Hattatoğlu TD, et al. Knowledge, attitude and behaviors of women between the ages of 40-69 on early detection of breast cancer. Turk J Fam Med Prim Care. 2019;13(2):119- 128. [CrossRef]
  • 24. Guo F, Kuo YF, Berenson AB. Breast cancer incidence by stage before and after change in screening guidelines. Am J Prev Med. 2019;56(1):100-108. [CrossRef]
  • 25. Noman S, Shahar HK, Abdul Rahman H, Ismail S, Abdulwahid Al-Jaberi M, Azzani M. The effectiveness of educational interventions on breast cancer screening uptake, knowledge, and beliefs among women: a systematic review. Int J Environ Res Public Health. 2020;18(1):263. [CrossRef]
  • 26. Keene MR, Heslop IM, Sabesan SS, Glass BD. Complementary and alternative medicine use in cancer: A systematic review. Complement Ther Clin Pract. 2019;35:33-47. [CrossRef]
  • 27. Behzadmehr R, Dastyar N, Moghadam MP, Abavisani M, Moradi M. Effect of complementary and alternative medicine interventions on cancer related pain among breast cancer patients: a systematic review. Complement Ther Med. 2020;49:102318. [CrossRef]
  • 28. Mokhatri-Hesari P, Montazeri A. Health-related quality of life in breast cancer patients: review of reviews from 2008 to 2018. Health Qual Life Outcomes. 2020;18(1):1.
  • 29. Buckner CA, Lafrenie RM, Dénommée JA, Caswell JM, Want DA. Complementary and alternative medicine use in patients before and after a cancer diagnosis. Curr Oncol. 2018;25(4): e275-e281. [CrossRef]
  • 30. Izydorczyk B, Kwapniewska A, Lizinczyk S, Sitnik- Warchulska K. Psychological resilience as a protective factor for the body image in post-mastectomy women with breast cancer. Int J Environ Res Public Health. 2018;15(6):1181. [CrossRef]
  • 31. Okanlı A. Kadınlarda mastektominin psikososyal etkileri. J Hum Sci. 2011;8(1):1-6.
  • 32. Kucukoner M, Isikdogan A, Arpaci E, et al. Adjuvant chemoradiation for gastric cancer: multicentric study of the Anatolian Society of Medical Oncology. Hepat ogast roent erolo gy. 2012;59(119): 2343-2347. [CrossRef]
  • 33. Saumoy M, Schneider Y, Shen N, Kahaleh M, Sharaiha RZ, Shah SC. Cost effectiveness of gastric cancer screening according to race and ethnicity. Gastroenterology. 2018;155(3):648-660. [CrossRef]
  • 34. Rawla P, Barsouk A. Epidemiology of gastric cancer: global trends, risk factors and prevention. Prz Gastroenterol. 2019;14(1):26-38. [CrossRef]
  • 35. Türkeli M, Aldemir MN, Şimşek M, et al. Efficacy and tolerability of chemotherapy in elderly patients with metastatic gastric cancer. Turk J Geriatr. 2016;19(1):27-34.
  • 36. Caglar E, Balaban K, Atasoy D, Sezgin Caglar AS, Akay A. The incidences of upper gastrointestinal and colorectal malignancies in Ağrı city of eastern Anatolia. Cumhuriyet Med J. 2019;41(3):537- 543. [CrossRef]
  • 37. Peksöz R, Borazan S. Muş bölgesindeki üst gastrointestinal sistem malignitelerinin özellikleri. Endoskopi Gastrointest. 2020;28(2):1-4. [CrossRef]
  • 38. Kandaz M, Ertekin MV, Bilici M. Retrospective analysis of patients with esophageal cancer treated with radiotherapy and/or chemoradiotherapy. Tumori. 2012;98(4):445-450. [CrossRef]
  • 39. Şahin ZA, Tan M, Polat H. Hopelessness, depression and social support with end of life Turkish cancer patients. Asian Pac J Cancer Prev. 2013;14(5):2823-2828. [CrossRef]
  • 40. Lewandowska A, Zych B, Papp K, et al. Problems, stressors and needs of children and adolescents with cancer. Children (Basel). 2021;8(12):1173. [CrossRef]
  • 41. Moosavi S, Rohani C, Borhani F, Akbari ME. Consequences of spiritual care for cancer patients and oncology nurses: a qualitative study. Asia Pac J Oncol Nurs. 2019;6(2):137-144. [CrossRef]
  • 42. Shrestha A, Martin C, Burton M, Walters S, Collins K, Wyld L. Quality of life versus length of life considerations in cancer patients: a systematic literature review. Psycho Oncology. 2019;28(7): 1367-1380. [CrossRef]
  • 43. Srivastava J, Shukla H, Kaushik S, Tewari M. Assessment of distress (depression, anxiety and stress) in Indian women with breast cancer: predictive role of spiritual well being. Ann Oncol. 2016;27:ix161-ix162.
  • 44. Nierop van Baalen C, Grypdonck M, Van Hecke A, Verhaeghe S. Associated factors of hope in cancer patients during treatment: a systematic literature review. J Adv Nurs. 2020;76(7):1520-1537. [CrossRef]
  • 45. Aslan G, Bakan AB, Kilic D. An investigation of the relationship between religious coping and life satisfaction in oncology patients aged 65 and over. Psychogeriatrics. 2021;21(3):279-287. [CrossRef]
  • 46. Kavradım ST, Özer ZC. Kanser tanısı alan hastalarda umut. Psikiyatr Güncel Yaklaşımlar. 2014;6(2):154-164.
  • 47. McDonough MH, Beselt LJ, Daun JT, et al. The role of social support in physical activity for cancer survivors: a systematic review. Psycho Oncology. 2019;28(10):1945-1958. [CrossRef]
  • 48. Finck C, Barradas S, Zenger M, Hinz A. Quality of life in breast cancer patients: associations with optimism and social support. Int J Clin Health Psychol. 2018;18(1):27-34. [CrossRef]
  • 49. He KJ, Yang XN, Zhu Z, et al. Clinical effect of micturition interruption exercise on urinary incontinence after radical prostatectomy. Support Care Cancer. 2022;30(4):3241-3247. [CrossRef]
  • 50. Dikmen HA, Terzioglu F. Effects of reflexology and progressive muscle relaxation on pain, fatigue, and quality of life during chemotherapy in gynecologic cancer patients. Pain Manag Nurs. 2019;20(1):47-53. [CrossRef]
  • 51. Sikorskii A, Niyogi PG, Victorson D, Tamkus D, Wyatt G. Symptom response analysis of a randomized controlled trial of reflexology for symptom management among women with advanced breast cancer. Support Care Cancer. 2020 ;28(3):1395-1404. [CrossRef]
  • 52. Karabulutlu EY, Akyil R, Karaman S, Karaca M. Investigation of sleep quality and psychological problems in cancer caregivers. Turk J Oncol. 2013;28(1):1-9. [CrossRef]
  • 53. Mollaei F, Borhani F, Abbaszadeh A, Khabazkhoob M. Correlation between spiritual wellbeing and burden of care in family caregivers of cancer patients. Hayat. 2019;24(4):296-309.
  • 54. Baran G. The burden of care and life satisfaction of the Turkish mothers of children with cancer. J Client-Centered Nurs Care. 2018;4(4):175-184. [CrossRef]
  • 55. Oven Ustaalioglu B, Acar E, Caliskan M. The predictive factors for perceived social support among cancer patients and caregiver burden of their family caregivers in Turkish population. Int J Psychiatry Clin Pract. 2018;22(1):63-69. [CrossRef]
  • 56. Gok Metin Z, Karadas C, Balci C, Cankurtaran M. The perceived caregiver burden among Turkish family caregivers providing care for frail older adults. J Transcult Nurs. 2019;30(3):222- 230. [CrossRef]
  • 57. Johansen S, Cvancarova M, Ruland C. The effect of cancer patients’ and their family caregivers’ physical and emotional symptoms on caregiver burden. Cancer Nurs. 2018;41(2):91-99. [CrossRef]
  • 58. Charalambous A, Berger AM, Matthews E, Balachandran DD, Papastavrou E, Palesh O. Cancerrelated fatigue and sleep deficiency in cancer care continuum: concepts, assessment, clusters, and management. Support Care Cancer. 2019;27(7):2747-2753. [CrossRef]
  • 59. Wen FH, Chen JS, Chou WC, et al. Family caregivers' subjective caregiving burden, quality of life, and depressive symptoms are associated with terminally ill cancer patients' distinct patterns of conjoint symptom distress and functional impairment in their last six months of life. J Pain Symptom Manage. 2019;57(1):64-72. [CrossRef]
  • 60. Karabulutlu EY. Coping with stress of family caregivers of cancer patients in Turkey. Asia Pac J Oncol Nurs. 2014;1(1):55-60. [CrossRef]
  • 61. Morimoto T, Schreiner AS, Asano H. Caregiver burden and health related quality of life among Japanese stroke caregivers. Age Ageing. 2003;32(2):218-223. [CrossRef]
  • 62. Parks SM, Novielli KD. A practical guide to caring for caregivers. Am Fam Physician. 2000; 62(12):2613-2622.
  • 63. Tanriverdi O, Yavuzsen T, Turhal S, et al. Depression and socio economical burden are more common in primary caregivers of patients who are not aware of their cancer: TURQUOISE Study by the Palliative Care Working Committee of the Turkish Oncology Group (TOG). Eur J Cancer Care (Engl). 2016;25(3):502-515. [CrossRef]
  • 64. Oechsle K, Ullrich A, Marx G, et al. Psychological burden in family caregivers of patients with advanced cancer at initiation of specialist inpatient palliative care. BMC Palliat Care. 2019;18(1):102. [CrossRef]
  • 65. Shin JY, Lim JW, Shin DW, et al. Underestimated caregiver burden by cancer patients and its association with quality of life, depression and anxiety among caregivers. Eur J Cancer Care (Engl). 2018;27(2):e12814. [CrossRef]
  • 66. Yıldız E, Dedeli Ö, Pakyüz SÇ. Kanser hastalarına bakım veren aile üyelerinin bakım yükü ve yaşam kalitesinin incelenmesi. Hemşirelikte Eğitim Araştırma Derg. 2016;13(3):216-225.
  • 67. Özlem U, Fadiloğlu Z. Kanser hastasına bakım verenlere uygulanan planlı eğitimin bakım veren yükü üzerine etkisi. Cumhuriyet Hemşirelik Derg. 2012;1(2):53-58.
  • 68. Marte C, George LS, Rutherford SC, et al. Unmet mental health needs in patients with advanced B-cell lymphomas. Palliat Support Care. 2022;20(3):328-333. [CrossRef]
  • 69. Lisy K, Langdon L, Piper A, Jefford M. Identifying the most prevalent unmet needs of cancer survivors in Australia: a systematic review. Asia Pac J Clin Oncol. 2019;15(5):e68-e78. [CrossRef]
  • 70. Orak OS, Sezgin S. Kanser hastasına bakım veren aile bireylerinin bakım verme yüklerinin belirlenmesi. J Psychiatr Nurs/Psikiyatri Hemsireleri Derneği. 2015;6(1).
APA ipek coban g, dincer a, KÖSE A (2022). Silently Proliferating: Cancer. , 115 - 119. 10.5152/eurasianjmed.2022.22325
Chicago ipek coban gülay,dincer aytap,KÖSE ASENA Silently Proliferating: Cancer. (2022): 115 - 119. 10.5152/eurasianjmed.2022.22325
MLA ipek coban gülay,dincer aytap,KÖSE ASENA Silently Proliferating: Cancer. , 2022, ss.115 - 119. 10.5152/eurasianjmed.2022.22325
AMA ipek coban g,dincer a,KÖSE A Silently Proliferating: Cancer. . 2022; 115 - 119. 10.5152/eurasianjmed.2022.22325
Vancouver ipek coban g,dincer a,KÖSE A Silently Proliferating: Cancer. . 2022; 115 - 119. 10.5152/eurasianjmed.2022.22325
IEEE ipek coban g,dincer a,KÖSE A "Silently Proliferating: Cancer." , ss.115 - 119, 2022. 10.5152/eurasianjmed.2022.22325
ISNAD ipek coban, gülay vd. "Silently Proliferating: Cancer". (2022), 115-119. https://doi.org/10.5152/eurasianjmed.2022.22325
APA ipek coban g, dincer a, KÖSE A (2022). Silently Proliferating: Cancer. Eurasian Journal of Medicine, 54(1), 115 - 119. 10.5152/eurasianjmed.2022.22325
Chicago ipek coban gülay,dincer aytap,KÖSE ASENA Silently Proliferating: Cancer. Eurasian Journal of Medicine 54, no.1 (2022): 115 - 119. 10.5152/eurasianjmed.2022.22325
MLA ipek coban gülay,dincer aytap,KÖSE ASENA Silently Proliferating: Cancer. Eurasian Journal of Medicine, vol.54, no.1, 2022, ss.115 - 119. 10.5152/eurasianjmed.2022.22325
AMA ipek coban g,dincer a,KÖSE A Silently Proliferating: Cancer. Eurasian Journal of Medicine. 2022; 54(1): 115 - 119. 10.5152/eurasianjmed.2022.22325
Vancouver ipek coban g,dincer a,KÖSE A Silently Proliferating: Cancer. Eurasian Journal of Medicine. 2022; 54(1): 115 - 119. 10.5152/eurasianjmed.2022.22325
IEEE ipek coban g,dincer a,KÖSE A "Silently Proliferating: Cancer." Eurasian Journal of Medicine, 54, ss.115 - 119, 2022. 10.5152/eurasianjmed.2022.22325
ISNAD ipek coban, gülay vd. "Silently Proliferating: Cancer". Eurasian Journal of Medicine 54/1 (2022), 115-119. https://doi.org/10.5152/eurasianjmed.2022.22325